Chlamydia antigens and corresponding DNA fragments and uses...

Details Chlamydia antigens and corresponding DNA fragments and uses... Chlamydia antigens and corresponding DNA fragments and uses...

2007-10-23

2007-10-23

Navarro, Mark (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S190100, C424S192100, C424S234100, C424S263100, C435S975000

Reexamination Certificate

active

11107823

ABSTRACT:
The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain ofChlamydia, specificallyC. pneumoniae. The vaccine and method employ a 60 kDa cysteine-rich membrane protein of a strain ofChlamydia pneumoniae. Modifications are possible within the scope of this invention.

REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
patent: 5776746 (1998-07-01), Denney, Jr.
patent: 6020191 (2000-02-01), Scaria et al.
patent: 6255082 (2001-07-01), Lizardi
patent: 6521745 (2003-02-01), Murdin et al.
patent: 6559294 (2003-05-01), Griffais et al.
patent: 6693087 (2004-02-01), Murdin et al.
patent: 6808713 (2004-10-01), Murdin et al.
patent: 6822071 (2004-11-01), Stephens et al.
patent: 7019125 (2006-03-01), Murdin et al.
patent: 7070792 (2006-07-01), Murdin et al.
patent: 7081245 (2006-07-01), Murdin et al.
patent: 2002/0044949 (2002-04-01), Kleanthous et al.
patent: 2002/0082402 (2002-06-01), Murdin et al.
patent: 2002/0094340 (2002-07-01), Murdin et al.
patent: 2002/0094965 (2002-07-01), Murdin et al.
patent: 2002/0099188 (2002-07-01), Murdin et al.
patent: 2002/0132994 (2002-09-01), Murdin et al.
patent: 2003/0100706 (2003-05-01), Murdin et al.
patent: 2004/0254130 (2004-12-01), Murdin et al.
patent: WO 9746709 (1997-12-01), None
patent: WO 9858953 (1998-12-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 00/24765 (2000-05-01), None
patent: WO00/27994 (2000-05-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 00/37494 (2000-06-01), None
patent: WO 00/46359 (2000-08-01), None
patent: WO 00/66739 (2000-11-01), None
patent: WO 01/21804 (2001-03-01), None
patent: WO 01/21811 (2001-03-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 01/46224 (2001-06-01), None
patent: WO 01/81379 (2001-11-01), None
patent: WO 01/85972 (2001-11-01), None
patent: WO 02/02606 (2002-01-01), None
patent: WO 02/08267 (2002-01-01), None
Vanrompay et al (Infection and Immunity vol. 66, No. 11, pp. 5494-5500, Nov. 1998).
Grayston et al. (1995)Journal of Infectious Diseases168:1231.
Campos et al. (1995)Investigation of Ophthalmology and Visual Science36:1477.
Grayston et al (1990)Journal of Infectious Diseases161:618.
Marrie (1993)Clinical Infectious Diseases. 18:501.
Wang et al (1986)Chlamydial infections. Cambridge University Press, Cambridge. p. 329.
Saikku et al. (1988)Lancet; ii:983.
Thom et al. (1992)JAMA268:68.
Linnanmaki et al. (1993) ,Circulation87:1030.
Saikku et al. (1992)Annals Internal Medicine116:273.
Melnick et al (1993)American Journal of Medicine95:499.
Shor et al. (1992)South African. Medical Journal82:158.
Kuo et al. (1993)Journal of Infectious Diseases167:841.
Kuo et al. (1993)Arteriosclerosis and Thrombosis13:1501.
Campbell et al (1995)Journal of Infectious Diseases172:585.
Chiu et al (1997)Circulation. 96(7) :2144-2148.
Ramirez et al (1996)Annals of Internal Medicine125:979.
Jackson et al. Abst. K121, p. 272, 36thICAAC, Sep. 15-18, 1996, New Orleans.
Fong et al (1997)Journal of Clinical Microbiology35:48.
Hahn DL, et al. “Evidence forChlamydia pneumoniaeinfection in steroid-dependent asthma”.Ann Allergy Asthma Immunol.Jan. 1998; 80(1): 45-49.
Hahn DL, et al. “Association ofChlamydia pneumoniaeIgA antibodies with recently symptomatic asthma”.Epidemiol Infec.Dec. 1996; 117 (3): 513-517.
Bjornsson E, et al. “Serology ofChlamydiain relation to asthma and bronchial hyperresponsiveness”.Scand J Infect Dis.1996; 28(1): 63-69.
Hahn DL. “Treatment ofChlamydia pneumoniaeinfection in adult asthma: a before-after trial”. J Fam Pract. Oct. 1995; 41(4): 345-351.
Allegra L, et al. “Acute exacerbations of asthma in adults”:role of Chlamydia pneumoniae infection. Eur Respir J. Dec. 1994; 7(12): 2165-2168.
Hahn DL, et al. “Association ofChlamydia pneumoniae(strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma”.JAMA. Jul. 10, 1991; 266(2): 225-230.
Pal et al. (1996)Infection and Immunity. 64:5341.
Jones et al. (1995)Vaccine13:715.
Igietseme et al (1993)Regional Immunology5:317.
Magee et al (1993)Regional Immunology5: 305.
Landers et al (1991)Infection&Immunity59:3774.
Magee et al (1995)Infection&Immunity63:516.
Cotter et al. (1995)Infection and Immunity63:4704.
Campbell et al (1990)Infection and Immunity58:93.
McCafferty et al (1995)Infection and Immunity63:2387-9.
Gaydos et al.; “Similarity ofChlamydia pneumoniaestrains in the Variable Domain IV Region of the Major Outer Membrane Protein Gene”; Infection and Immunity; 60(12):5319-5323. Dec. 1992.
Wiedmann-Al-Ahmad M, et al. “Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein ofChlamydia pneumoniae”. Clin Diagn Lab Immunol.Nov. 1997; 4(6:700-704).
Hughes et al., 1992.Infect. Immun.60(9) :3497.
Dion et al., 1990.Virology179:474-477.
Snijders et al., 1991.J. Gen. Virol.72:557-565.
Langeveld et al.,Vaccine12(15):1473-1480, 1994.
Ausubel et al.,Current Protocols in Molecular Biology, John Wiley & Sons Inc., 1994.
Kunkel et al.Proc. Natl. Acad. Sci.USA (1985) 82:448.
Silhavy et al. “Experiments with Gene Fusions”,Cold Spring Harbor Laboratory Press, 1984.
Davis et al. “A Manual for Genetic Engineering: Advanced Bacterial Genetics”,Cold Spring Harbor Laboratory Press, 1980).
Casey & Davidson,Nucl. Acid Res.(1977) 4:1539.
Cagnon et al.,Protein Engineering(1991) 4(7):843.
Takase et al.,J. Bact.(1987) 169:5692.
Perez Melgosa et al.,Infect Immun(1994) 62:880.
Watson et al., Nucleic Acids Res (1990) 18:5299.
Watson et al.,Microbiology(1995) 141:2489.
Melgosa et al.,FEMS Microbiol Lett(1993) 112 :199.
Campbell et al.,J Clin Microbiol(1990) 28 :1261.
Iijima et al.,J Clin Microbiol(1994) 32:583.
Bachmaier et al., Science (1999) 283:1335.
Ausubel et al.; “Current Protocols in Molecular Biology”; John Wiley & Sons Inc.; vol. 1; 1994; 15 sheets.
Silhavy et al.; “Experiments with Gene Fusions”; Cold Spring Harbor Laboratory Press; 194; pp. 191-195.
Davis et al., “A Manual for Genetic Engineering: Advanced Bacterial Genetics” Cold Spring Harbor Laboratory Press; 1980; pp. 174-176.
Watson et al. 1990. Nucleic Acids Research. 18(17) :5299.
Watson et al. 1994. Microbiology. 140 (8) :2003-2011.
Wagels et al. 1994. J. Clinical Microbiology. 32(11):2820-2823.
Watson et al. 1990. Nucleic Acids Research. 18(17):5300.
Plotkin et al. “Vaccines” W. B. Saunders Co. Philadelphia. 1998. p. 571.
Mygind et al., “Analysis of the Humoral Immune Response toChlamydiaOuter Membrane Protein 2,”Clinical and Diagnostic Laboratory Immunology, vol. 5, No. 3, May 1998, pp. 313-318.
Allen et al., “An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen,Chlamydia trachomatis, ”Eur. J. Immunol., vol. 23, 1993, 1169-1172.
U.S. Appl. No. 09/857,128, filed Sep. 20, 2001, Murdin et al.
U.S. Appl. No. 09/868,987, filed Dec. 23, 1999, Murdin et al.
U.S. Appl. No. 09/471,194, filed Dec. 23, 1999, Murdin et al.
U.S. Appl. No. 09/522,606, filed Mar. 10, 2000, Murdin et al.
U.S. Appl. No. 09/609,243, filed Jun. 30, 2000, Murdin et al.
U.S. Appl. No. 09/662,813, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,362, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,360, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/663,361, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/662,814, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/662,812, filed Sep. 15, 2000, Murdin et al.
U.S. Appl. No. 09/709,473, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/709,474, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/709,384, filed Nov. 13, 2000, Murdin et al.
U.S. Appl. No. 09/747,349, filed Dec. 22, 2000, Murdin et al.
Stephens et al., “Genome Sequence of an Obligate Intracellular Pathogen of Humans:Chlamydia trachomatis,” Oct. 23, 1998, vol. 282, Science, pp. 754-759.
Kalman et al.

Affiliated with

Also associated with

Rating

Chlamydia antigens and corresponding DNA fragments and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chlamydia antigens and corresponding DNA fragments and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens and corresponding DNA fragments and uses... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3899616